Latest filing published 07 Jan 2016 for Galectin Therapeutics INC, €2,647.
Insider track record
No signal scores available.
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -29.2%Entry US$1.44 · Close at T+365 US$1.02
- -64.8%Entry US$5.22 · Close at T+365 US$1.84
- -45.0%Entry US$7.64 · Close at T+365 US$4.20
- +67.6%Entry US$2.90 · Close at T+365 US$4.86
- +31.2%Entry US$2.95 · Close at T+365 US$3.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Arthur Greenberg: trading record in brief
This profile gathers the share dealings of Arthur Greenberg in Galectin Therapeutics Inc. The record holds 7 filings, for trades running from 16 June 2011 to 5 January 2016.
On the market, this insider has only ever bought: 6 purchases, €47k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. Since January 2016: 1 purchase and no sales on the market.
A typical purchase (the median) is worth €6,990. Looking at 6 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -12.8%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 7 January 2016, reports an open-market purchase of €2,647 in Galectin Therapeutics Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arthur Greenberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,666 shares@ US$1.72100.0% of flowCommon StockSEC:0001179022-16-000091:0Canonical exit: 4 Apr 2016 (T+90)
- 11,112 shares0Common StockSEC:0001179022-15-000083:0
- 1,000 shares@ US$4.56Common StockSEC:0000914062-14-000230:0Canonical exit: 17 Nov 2014 (T+90)
- 2,000 shares@ US$6.55Common StockSEC:0000914062-13-000330:0Canonical exit: 17 Feb 2014 (T+90)
- 5,000 shares@ US$1.84Common StockSEC:0001181431-12-041525:0Canonical exit: 16 Oct 2012 (T+90)
- 3,000 shares@ US$2.84Common stockSEC:0001181431-12-024613:0Canonical exit: 16 Jul 2012 (T+90)
- 20,000 shares@ US$1.21Common StockSEC:0001209191-11-035207:0Canonical exit: 14 Sept 2011 (T+90)
7 of 7 declarations
